Stemedica Stock

stemedica.comBioTechFounded: 2005Funding to Date: $82.12MM

Stemedica Cell Technologies is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions.

Register for Details

For more details on financing and valuation for Stemedica, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Maynard Howe Ph.D
Co-Founder, Vice Chairman & Chief Executive Officer
Craig Carlson
Chief Executive Officer
Alex Kharazi Ph.D
Chief Technology Officer
Lev Verkh Ph.D
Chief Regulatory and Clinical Development Officer
Roger Howe Ph.D
Chairman and Co-Founder
Nikolai Tankovich MD
President, Board Member and Chief Medical Officer

Board Members

Anthony Marlon MD
Byung-Geon Rhee Ph.D
Green Cross Holdings
Dirk O'Hara JD
Gary Petrucci
Guochao Liu
Maynard Howe Ph.D
Neal Matheson
Nikolai Tankovich MD
Richard Mejia Jr.
Roger Howe Ph.D
Sergey Leshkov
Simon Guo
William Maloney MD

Other companies like Stemedica in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM